NEI Research News

The brain works in fundamentally different ways when remembering what we have seen compared to seeing something for the first time, a team of scientists has found.

A basic research study from the National Eye Institute (NEI) explains how the molecule transducin moves within light-sensing rod photoreceptors in mouse retina to help the eye quickly adapt from bright to low light and back.

An enzyme under study to treat certain cancers is also showing promise in reducing the significant vision damage that can result from diabetes and premature birth, scientists report.

Series fosters global collaboration and exchange of information among international vision researchers and eye health clinical scientists

National Eye Institute researchers mapped the organization of human retinal cell chromatin, the fibers that package 3 billion nucleotide-long DNA molecules into compact structures that fit into chromosomes within each cell’s nucleus.

University of California, Irvine team demonstrates the adult brain has the potential to partially recover from inherited blindness.

Study from UT Southwestern Medical Center could lead to new treatments for deadly childhood eye cancer.

A graduate student at the National Eye Institute, Preston volunteered this summer as a virtual instructor in the 8-week-long Journal of Emerging Investigators Mini Ph.D. Program.

The protocol gives step-by-step instructions, starting with patient-derived pluripotent stem cells, transitioning them to retinal pigment epithelium (RPE) cells and finally maturing them into RPE tissue.

Fulya Yaylacıoğlu Tuncay, M.D., Ph.D., said she gained crucial experience in translational medicine as the first participant in an ocular genetics fellowship program sponsored by NEI and the International Council of Ophthalmology.